7377 CAM2029, Octreotide Subcutaneous Depot, Improves Patient-Reported Outcomes from Standard-of-Care Baseline in Patients with Acromegaly: Interim Results from a Phase 3 Study (ACROINNOVA 2)
Journal of the Endocrine Society（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined